Accumulation of mutations in both gyrB and parE genes is associated with high-level resistance to novobiocin in Staphylococcus aureus.
about
Mechanism of inhibition of DNA gyrase by ES-1273, a novel DNA gyrase inhibitor.Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitorsWhole-Genome Sequence Analysis of Antimicrobial Resistance Genes in Streptococcus uberis and Streptococcus dysgalactiae Isolates from Canadian Dairy Herds.Multilocus sequence typing and further genetic characterization of the enigmatic pathogen, Staphylococcus hominis.Influence of a non-hospital medical care facility on antimicrobial resistance in wastewater.Protective effect of Qnr on agents other than quinolones that target DNA gyrase.Strategies for target identification of antimicrobial natural products.Anucleate cell blue assay: a useful tool for identifying novel type II topoisomerase inhibitors.Staphylococcus aureus TargetArray: comprehensive differential essential gene expression as a mechanistic tool to profile antibacterials.ARG-ANNOT, a new bioinformatic tool to discover antibiotic resistance genes in bacterial genomes.Intrinsic novobiocin resistance in Staphylococcus saprophyticus.Staphylococcus aureus promoter-lux reporters for drug discovery.DNA gyrase activity regulates DnaA-dependent replication initiation in Bacillus subtilis.Prevalence and Genetic Basis of Antimicrobial Resistance in Non-aureus Staphylococci Isolated from Canadian Dairy Herds.In vitro antibacterial resistance selection and quantitation.Inhibition of DNA gyrase and DNA topoisomerase IV of Staphylococcus aureus and Escherichia coli by aminocoumarin antibiotics.
P2860
Q33303368-9D9A5FDE-6F86-4B51-989E-98AD3544D529Q33339829-D3FEE3C1-EDCA-43A5-B30B-E569BA868F04Q33710896-4A69170B-E4C3-466C-9931-2A1ACDB4657EQ34776738-CDEB8AE0-AED2-49ED-8D5D-A96297174F5EQ35589786-BA640AD8-8116-488A-AEAE-C77633D33AB4Q36158288-E7B7908D-7C6F-44A5-ACD3-374941E568DAQ38710256-16E333DF-4C6B-458D-8501-6D1284BA520AQ41790139-20A164DF-20BD-4F70-90B3-EA9823CE3216Q41835213-2A920136-7937-4041-B806-AA298FE1E1D7Q41907446-26F0C6B7-3D2D-44BF-8CEC-9A8D3BF73332Q42909065-159C9085-A8B9-49D2-A56C-E9F1672E0AD9Q42981005-993EAB27-BA3B-42E5-B535-638E85AC26AEQ48111138-2B32B980-F047-41A8-BF9C-92BC667DCED9Q50351287-F506D87D-0086-449C-95F4-C6B863D367E3Q53596428-575844E5-7987-4342-9F4A-1F42AEC67E3BQ54358881-84CE2481-F080-4C25-99D2-E3EFF2DF61E7
P2860
Accumulation of mutations in both gyrB and parE genes is associated with high-level resistance to novobiocin in Staphylococcus aureus.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Accumulation of mutations in b ...... ocin in Staphylococcus aureus.
@ast
Accumulation of mutations in b ...... ocin in Staphylococcus aureus.
@en
Accumulation of mutations in b ...... ocin in Staphylococcus aureus.
@nl
type
label
Accumulation of mutations in b ...... ocin in Staphylococcus aureus.
@ast
Accumulation of mutations in b ...... ocin in Staphylococcus aureus.
@en
Accumulation of mutations in b ...... ocin in Staphylococcus aureus.
@nl
prefLabel
Accumulation of mutations in b ...... ocin in Staphylococcus aureus.
@ast
Accumulation of mutations in b ...... ocin in Staphylococcus aureus.
@en
Accumulation of mutations in b ...... ocin in Staphylococcus aureus.
@nl
P2093
P2860
P1476
Accumulation of mutations in b ...... ocin in Staphylococcus aureus.
@en
P2093
Hideaki Ito
Jun-Ichi Yamagishi
Mika Fujimoto-Nakamura
Takeshi Nishino
Yoshihiro Oyamada
P2860
P304
P356
10.1128/AAC.49.9.3810-3815.2005
P407
P577
2005-09-01T00:00:00Z